We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

AB SCIEX Drives 6500 Series to Top of Triple Quadrupole Market

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute

AB SCIEX will mark the one-year anniversary of the introduction of the AB SCIEX 6500 series by bringing together more than a thousand mass spectrometry users on Sunday and throughout next week to share insight, data and experiences with what has now become the industry’s top-selling, high-end triple quadrupole.

The AB SCIEX 6500 has been installed in hundreds of laboratories around the world in less than a year, ranging from pharmaceutical companies to academic institutions to applied scientific laboratories.

Responding to growing market demand for next-generation technology for quantitation, AB SCIEX will reveal brand new data on the 6500 series at its Users Meeting on Sunday, June 9, just hours before the start of the American Society for Mass Spectrometry (ASMS) conference in Minnesota.

The 6500 system is a high-performance triple quadrupole with high sensitivity. Differentiating this instrumentation is the QTRAP® version for integrated quantitative and qualitative analysis as well as SelexION™ Differential Mobility Separation Technology, which adds yet another dimension of selectivity for analyzing complex samples.

Among the customers who have adopted the QTRAP® 6500 system for quantitation, along with the TripleTOF®5600 System for discovery, is Jenny Van Eyk, a senior researcher at Johns Hopkins University.

Dr. Van Eyk will speak at the AB SCIEX Users Meeting about her collaborative work with AB SCIEX to develop automated workflows for targeted quantitative proteomics.

Focused on advancing heart and vascular disease research, Dr. Van Eyk is seeking to identify and validate new markers to potentially bring into the clinic someday.

In addition to a large discovery program, she is analyzing thousands of samples in her validating program to assess which protein targets could have the most clinical utility. The 6500 system is an ideal instrument for her type of research.

“Customers have been using the 6500 system in their lab for almost a year now and the feedback has been tremendously positive,” said Markus Lusser, Vice President of Global Sales and Customer Support at AB SCIEX.

Lusser continued, “Providing leading-edge technologies to innovators such as Dr. Van Eyk, so they can advance their research, is highly motivating and a reason why AB SCIEX continues to push the limits in our innovation pipeline of new products.”

The AB SCIEX Users Meeting on Sunday will focus on celebrating the success of hundreds of customers, including over 30 scientists who will be presenting.

Like Dr. Van Eyk, these customers have been able to advance their scientific pursuits through the use of the 6500 system as well as other AB SCIEX platforms.